Valens Molecules Private Limited

U24100TG1994PTC018680ActivePrivateUnlisted
Last updated: 2026-06-07
30
Compliance Health · F
3 / 9 signals passed

Valens Molecules Private Limited is a Private Indian company incorporated in 1994 and based in Telangana, India. Valens Molecules Private Limited operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
Awaiting extraction
PAT (latest FY)
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
Filings on Record
0
All current
Incorporated
1994
32 years old
State
Telangana
Sector
Pharmaceuticals & Chemicals
NIC 24100
Class
Private
Sub-category
Authorized Capital
Paid-up Capital
Members
Last AGM
Last Balance Sheet
Latest Filing
Registered Email
Registered Office
VALENS MOLECULES PRIVATE LIMITEDTRACXN · PUBLIC DATA
Brand VALENS MOLECULES PRIVATE LIMITED · Legal entity Valens Molecules Private Limited
Total Funding
Latest Round
Revenue
Valuation
Funding Rounds
Employees
Stage
HQ
Founded
1994
Source: Tracxn (public profile) · joined to MCA on CIN U24100TG1994PTC018680

Quick facts

Identity · Activity · Auditor · Contact
Registered office
NIC code
24100
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
Section
Pharmaceuticals & Chemicals
ROC
Class · sub-category
Private
Incorporation · Last AGM
·

Directors

From MGT-7 annual returnLocked
VS
Vikram Singh Rathore
Director
5.6y · Pune · DIN 9990541
PN
Priya Nair
Whole-time Director
5.0y · Pune · DIN 1741823
SI
Suresh Iyer
Director
1.7y · Pune · DIN 4706308
Get the full board of directors

Directors, DINs & appointment history for Valens Molecules Private Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2520 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 20230dfiled
MGT-7FY2023-2422 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 2022+2dfiled
MGT-7FY2022-2323 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Valens Molecules Private Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
607995562HDFC Bank Ltd(Bank)₹16.27 Cr27 Jan 2020Open
676744783ICICI Bank Ltd(Bank)₹20.96 Cr19 Sep 2023Satisfied
141140150State Bank of India(Bank)₹21.66 Cr27 Jan 2020Satisfied
538144865ICICI Bank Ltd(Bank)₹14.39 Cr27 Jan 2019Satisfied
614406944HDFC Bank Ltd(Bank)₹5.65 Cr12 Mar 2021Open
See registered charges & lenders

Charge IDs, lenders & amounts for Valens Molecules Private Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹15.55 Cr₹2.29 Cr₹15.57 Cr₹23.88 Cr348
FY2023-24₹12.13 Cr₹1.59 Cr₹6.88 Cr₹12.38 Cr187
FY2022-23₹13.45 Cr₹2.00 Cr₹9.27 Cr₹18.52 Cr251
FY2021-22₹8.96 Cr₹1.26 Cr₹5.26 Cr₹10.16 Cr229
Gain deeper financial insights of this entity

Audited financials & ratios for Valens Molecules Private Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹15.55 Cr₹12.13 Cr₹13.45 Cr₹8.96 Cr
Other income₹10.12 L₹9.13 L₹49.62 L₹23.53 L
Total income₹15.65 Cr₹12.22 Cr₹13.95 Cr₹9.20 Cr
Total expenses₹12.72 Cr₹10.19 Cr₹11.38 Cr₹7.59 Cr
Profit before tax₹2.98 Cr₹2.06 Cr₹2.60 Cr₹1.63 Cr
Profit / (Loss) after tax₹2.29 Cr₹1.59 Cr₹2.00 Cr₹1.26 Cr
Balance sheet
Equity / Net worth₹15.57 Cr₹6.88 Cr₹9.27 Cr₹5.26 Cr
Borrowings₹2.95 Cr₹1.74 Cr₹1.99 Cr₹1.24 Cr
Current liabilities₹2.80 Cr₹2.51 Cr₹3.58 Cr₹2.93 Cr
Total liabilities₹8.31 Cr₹5.49 Cr₹9.25 Cr₹4.90 Cr
Current assets₹12.83 Cr₹6.75 Cr₹10.67 Cr₹4.42 Cr
Cash & equivalents₹4.40 Cr₹1.18 Cr₹1.38 Cr₹77.76 L
Total assets₹23.88 Cr₹12.38 Cr₹18.52 Cr₹10.16 Cr
Employees348187251229
Gain deeper financial insights of this entity

Audited financials & ratios for Valens Molecules Private Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹15.55 Cr+1.6%+7.6%+19.9%
Profit after Tax₹2.29 Cr+13.6%-0.8%-1.0%
Net Worth₹15.57 Cr+34.4%+3.5%+5.7%
Employees348-7.8%+12.7%+3.9%
Gain deeper financial insights of this entity

Audited financials & ratios for Valens Molecules Private Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹15.55 Cr₹2.29 Cr+14.74%+25.40%+14.72%+9.60%0.19₹4.47 L
FY2023-24₹12.13 Cr₹1.59 Cr+13.07%+9.49%+23.05%+12.82%0.25₹6.49 L
FY2022-23₹13.45 Cr₹2.00 Cr+14.89%-12.78%+21.62%+10.82%0.21₹5.36 L
FY2021-22₹8.96 Cr₹1.26 Cr+14.03%+26.20%+23.90%+12.38%0.24₹3.91 L
Gain deeper financial insights of this entity

Audited financials & ratios for Valens Molecules Private Limited.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters22,61,27,90371.00%
Institutional Investors118,82,7145.12%
Public & Others1487,89,78323.89%
See the full shareholding pattern

Promoter, institutional & public holding for Valens Molecules Private Limited.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

50 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
PAT (latest FY)
Employees
Paid-up capital
Compliance Health
63
96
96
Bottom quartile · P0

Top 10 in Pharmaceuticals & Chemicals

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
S B Organics Ltd
Telangana · Inc 1988
Paid-up
Revenue
A · 96
06
Ecmas Resins PVT Ltd
Telangana · Inc 1987
Paid-up
Revenue
A · 96
07
Srinivasa Cystine Private Ltd
Telangana · Inc 1983
Paid-up
Revenue
A · 96
08
Paid-up
Revenue
A · 96
09
Paid-up
Revenue
A · 96
10
Paid-up
Revenue
A · 96

Events & timeline

1Filings, charges, board changes
07 Jan 2013
Rahul appointed as Director

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Valens Molecules Private Limited

When was Valens Molecules Private Limited incorporated?
Valens Molecules Private Limited was incorporated in 1994. Its CIN is U24100TG1994PTC018680 and it is registered with the relevant Registrar of Companies.
Where is Valens Molecules Private Limited located?
Valens Molecules Private Limited is headquartered in Telangana.
What sector does Valens Molecules Private Limited operate in?
Valens Molecules Private Limited operates in the Pharmaceuticals & Chemicals sector (NIC code 24100), classified as Indian Non-Govt Company.
Who are the directors of Valens Molecules Private Limited?
Director details for Valens Molecules Private Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Valens Molecules Private Limited?
Valens Molecules Private Limited has authorized capital of — and paid-up capital of —.
Does Valens Molecules Private Limited have any open charges?
Valens Molecules Private Limited has no open MCA-registered charges on record.
What is Valens Molecules Private Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Valens Molecules Private Limited is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.